New insights into the role of apoptosis in cardiovascular disease

Circulation Journal

Volumn 66, Issue 1, 2002, Pages 1-9

  Kang, Peter M ^a   Yue, Patrick ^a   Izumo, Seigo ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; DNA; FAS ANTIGEN; FAS LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; CARDIOVASCULAR DISEASE; DNA DETERMINATION; HEART FAILURE; HEART HYPERTROPHY; HEART MITOCHONDRION; ISCHEMIC HEART DISEASE; KNOCKOUT MOUSE; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CARDIOVASCULAR DISEASES; HUMANS; MAP KINASE SIGNALING SYSTEM; MODELS, CARDIOVASCULAR; SIGNAL TRANSDUCTION;

EID: 0036242344     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.1     Document Type: Review

References (114)

1. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
2. Apoptosis in the failing human heart
3. Apoptosis in human acute myocardial infarction
4. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes
5. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes
6. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53
7. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation
8. Apoptosis in ischemic and reperfused rat myocardium
9. Reperfusion injury induces apoptosis in rabbit cardiomyocytes
10. Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes
11. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor
12. Apoptosis and heart failure: A critical review of the literature
13. Myocyte apoptosis is sufficient to cause dilated cardiomyopathy
14. Apoptosis in heart failure: Is there light at the end of the tunnel (TUNEL)?
15. Enhanced Galphaq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure
16. Apoptosis of cardiac myocytes in Gsalpha transgenic mice
17. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro
18. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat
19. Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure
20. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress
21. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis In vitro and In vivo: An apoptosis-independent model of dilated heart failure
22. Insulin-like growth factor I improves cardiovascular function and suppresses apoptosis of cardiomyocytes in dilated cardiomyopathy
23. Overexpression of insulin-like growth factor-I in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy
24. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy
25. Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training
26. Caspases: Killer proteases
27. Caspases: Enemies within
28. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
29. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
30. Apaf-1, a human protein homologous to C.elegans CED-4, participates in cytochrome c-dependent activation of caspase-3
31. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner
32. IAP family proteins: Suppressors of apoptosis
33. The Bcl-2 protein family: Arbiters of cell survival
34. Apoptosis by death factor
35. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
36. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
37. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death
38. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
39. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
40. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes
41. Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy
42. Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury
43. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice
44. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats
45. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction
46. Programmed myocyte cell death affects the viable myocardium after infarction in rats
47. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs
48. Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure
49. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol
50. Levels of soluble Fas ligand in myocarditis
51. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure
52. The Fas/Fas ligand system is involved in the pathogenesis of autoimmune myocarditis in rats
53. Proinflammatory consequences of transgenic fas ligand expression in the heart
54. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha
55. Inhibition of death receptor signals by cellular FLIP
56. Arc, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases
57. ARC inhibits cytochrome c release from mitochondria and protects against hypoxia-induced apoptosis in heart-derived H9c2 cells
58. Signal transduction by the JNK group of MAP kinases
59. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart: p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion
60. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart
61. Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase I-regulated response element in the Fas ligand promoter
62. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation
63. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G (2)/M
64. Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x (L) in response to DNA damage
65. Novel role for JNK as a stress-activated Bc12 kinase
66. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
67. Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis
68. MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes
69. Regulation of neuronal survival by the serine-threonine protein kinase Akt
70. Interleukin-3 -induced phosphorylation of BAD through the protein kinase Akt
71. P13K: Downstream AKTion blocks apoptosis
72. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway
73. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
74. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X (L)
75. Regulation of cell death protease caspase-9 by phosphorylation
76. Phophatidylinositol 3-kinase in myogenesis
77. Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1
78. Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt
79. Adenoviral gene transfer of activated phosphatidylinositol 3′-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro
80. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo
81. Akt promotes survival of cardiomyocytes in vitro and protects against ischemiareperfusion injury in mouse heart
82. Bax-deficient mice with lymphoid hyperplasia and male germ cell death
83. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues
84. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice
85. Bcl-w is an important determinant of damage-induced apoptosis in epithelia of small and large intestine
86. Massive cell death of immature hematopoietic cells and neurons in Bcl-x- deficient mice
87. Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-lbeta-converting enzyme (caspase-1)-deficient mice
88. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme
89. Mice deficient in IL-I beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock
90. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE
91. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta
92. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice
93. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
94. Differential requirement for caspase 9 in apoptotic pathways in vivo
95. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apol, and DR3 and is lethal prenatally
96. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
97. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver
98. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis
99. Mice lacking the turnout necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes
100. Tumor spectrum analysis in p53-mutant mice
101. Apafl (CED-4 homolog) regulates programmed cell death in mammalian development
102. Characterization of XIAP-deficient mice
103. Developing a strategy to define the effects of insulin-like growth factor-I on gene expression profile in cardiomyocytes
104. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy
105. Gene program for cardiac cell survival induced by transient ischemia in conscious pigs
106. Gene expression profile in mouse myocardium after ischemia
107. Altered patterns of gene expression in response to myocardial infarction
108. Effects of early angiotensinconverting enzyme inhibition on cardiac gene expression after acute myocardial infarction
109. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays
110. Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury
111. Insulin-like growth factor-binding protein-3 induces fetalization in neonatal rat cardiomyocytes
112. Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy
113. Host gene regulation during coxsackievirus B3 infection in mice: Assessment by microarrays
114. A comparison of gene expression in murine cardiac allografts and isografts by means DNA microarray analysis